NXTSNasdaqPharmaceutical PreparationsFiscal year ends December 31
Nexentis Technologies Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$0.64−0.00 (-0.73%)
Close on Oct 19, 2026
- Market cap
- $522.65K
- P/E (TTM)
- –
- Dividend yield
- –
Nexentis Technologies Inc. revenue by segment
By business segment
By product or service
By region
| Revenue | Q4 25 | Q4 24 | Q3 24 | Q2 24 | Q1 24 | Q4 23 | Q3 23 | Q2 23 | Q1 23 | Q4 22 | Q3 22 | Q2 22 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United States | – | $131.25K | $778 | – | $38.98K | $100.45K | $0 | $0 | $41.55K | $127.70K | $0 | $0 | – | – |
| Israel | – | $3.37K | $8.33K | $14.45K | $4.86K | $4.78K | $0 | $0 | $5.22K | $15.48K | $3.30K | $0 | – | – |
| Mexico | – | – | – | – | – | $176 | $0 | $36.61K | $73.22K | $34.94K | $47.93K | $31.08K | – | – |
| Türkiye | – | – | – | – | – | $0 | $0 | – | $1.02K | – | – | – | – | – |
| Peru | – | $5.90K | $0 | $2.10K | – | – | – | – | – | – | – | – | – | – |
From the segment and revenue-disaggregation notes of Nexentis Technologies's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.